Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-20

FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)

View source ↗

Summary

FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) with Voyant Beauty as the manufacturer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAMISIL AT CREAM (TERBINAFINE HYDROCHLORIDE)

Snippet

SUPPL AP for LAMISIL AT CREAM (TERBINAFINE HYDROCHLORIDE)